<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00172380</url>
  </required_header>
  <id_info>
    <org_study_id>930911</org_study_id>
    <nct_id>NCT00172380</nct_id>
  </id_info>
  <brief_title>Phase II Study of Docetaxel Plus CDDP for NSCLC Stage III</brief_title>
  <official_title>Phase II Study Evaluating Docetaxel and CDDP as Neoadjuvant Chemotherapy Prior to Surgery, Followed by Adjuvant Docetaxel Plus CDDP in Chemonaive Patients With NSCLC Stage III</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the overall response rate to docetaxel plus CDDP as neoadjuvant chemotherapy prior
      to surgery, followed by adjuvant docetaxel plus CDDP in chemonaive patients NSCLC Stage IIIa
      and IIIb.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2005</start_date>
  <completion_date type="Actual">March 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>overall response rate</measure>
    <time_frame>every cycle during 2nd-6th cycles</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>resectability</measure>
    <time_frame>resectability after treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>progression free survival</measure>
    <time_frame>progression free survival after 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>overall survival</measure>
    <time_frame>overall survival at 1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>NSCLC</condition>
  <arm_group>
    <arm_group_label>docetaxel and cisplatin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>docetaxel 36mg/m2 and cisplatin 75mg/m2</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Docetaxel Plus CDDP</intervention_name>
    <description>docetaxel 36mg/m2 and cisplatin 75mg/m2</description>
    <arm_group_label>docetaxel and cisplatin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histologically or cytologically confirmed NSCLC, respectable NSCLC stage IIIa T1-2 N2
             or or unresectable stage IIIb 2.KPS&gt;70%
             3.Hb&gt;10g/dl,ANC&gt;2.0x109/L,Plt.&gt;100x109/L4.T-bil.&lt;1xULN,creatinine&lt;1xULN,creatinine
             clearance &gt;60 ml/min,GPT/GOT&lt;2.5xULN,ALP&lt;5xULN

        Exclusion Criteria:

          -  1.Brain meta.2..Prior surgery,R/T, C/t or immunotherapy for NSCLC
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chong-Jen Yu, M.D,Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Internal Medicine, National Taiwan University hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Internal Medicine, National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2005</study_first_posted>
  <last_update_submitted>December 19, 2012</last_update_submitted>
  <last_update_submitted_qc>December 19, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 20, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Docetaxel</mesh_term>
    <mesh_term>Cisplatin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

